FDA to Include Animal Drugs in EU Mutual Recognition Agreement for Pharmaceutical Good Manufacturing Practice Inspections
18 Mar 2020

The U.S. Food and Drug Administration is announcing that the FDA’s Center for Veterinary Medicine (CVM) reported to the European Union (EU) and Commission (EC) during the December 2019 Joint Sectoral Committee meeting of CVM’s decision to include veterinary pharmaceuticals as part of the FDA/EU Mutual Recognition Agreement (MRA) for Pharmaceutical Good Manufacturing Practice Inspections.

http://www.fda.gov/animal-veterinary/cvm-updates/fda-include-animal-drugs-eu-mutual-recognition-agreement-pharmaceutical-good-manufacturing-practice